SciClone downgraded at Cowen As previously reported, Cowen downgraded to Neutral from Outperform. The firm cites the sequential decline in Q2 sales growth, supply shortages, and increased government scrutiny of large therapeutics for the downgrade.
News For SCLN From The Last 14 Days
Check below for free stories on SCLN the last two weeks.